Connect with us

Life Sciences

Boost Medical Group Selects Trevelino/Keller to Launch and Scale New Brand

Outcome-Focused Firm Selected as Growth Marketing and PR Partner for Experience in Technology, Professional Services, and Healthcare Industries Trevelino/Keller,…

Published

on

This article was originally published by AITHORITY
Boost Medical Group Selects TrevelinoKeller to Launch and Scale New Brand

Outcome-Focused Firm Selected as Growth Marketing and PR Partner for Experience in Technology, Professional Services, and Healthcare Industries

Trevelino/Keller, a nationally ranked growth PR and marketing firm, announced a new partnership with Boost Medical Group, the industry’s first end-to-end diagnostic and case management solution designed to revolutionize the personal injury space. Trevelino/Keller will support Boost Medical Group with a 360-degree growth marketing and PR approach, encompassing branding, website development, lead generation and earned media.

 Latest Hybrid Natural Language Insights : Expert.ai Announces New Features to Hybrid Natural Language Platform

“This bold, innovative thinking aligns well with our agency, as we regularly partner with clients blazing their own path in the industries they serve. We look forward to supporting Boost Medical in what’s ahead, as they’re poised to disrupt the personal injury space.”

Traditionally, if someone withstands an injury, the options for diagnosis and treatment hinge upon a CT or MRI scan. However, those methods alone aren’t enough to effectively quantify someone’s injuries or paint a holistic picture in court. Boost Medical Group aims to disrupt this outdated standard with a quantifiable solution that provides empirical data to attorneys and their clients – helping demonstrate the extent and impact of an injury and successfully expedite and resolve cases in less time.

“Our goal at Boost Medical is to provide attorneys and their clients with a complete and efficient solution that can make a difference for case outcomes,” stated Bob Hopta, managing partner at Boost Medical Group. “As a newly launched brand in the space, we see a lot of growth potential and the opportunity to infiltrate an industry historically lacking in the technology innovation we bring to the table. We know Trevelino/Keller will be a critical partner in helping us achieve these growth goals.”

Read More NLP NewsLion Announces It Will Explore ChatGPT Related AI & NLP Technologies To Empower Digital Program

Boost Medical Group’s highly validated methodology includes proprietary technology with 8 FDA clearances, more than a dozen peer-reviewed clinical publications and thousands of subject evaluations. Its six-step process encompasses screening and intake, referrals, diagnostics, impairment rating assignment, demand creation and case management.

“Boost Medical Group is aiming to solve a problem that no other has tried – or been successful – tackling,” noted Dean Trevelino, principal at Trevelino/Keller. “This bold, innovative thinking aligns well with our agency, as we regularly partner with clients blazing their own path in the industries they serve. We look forward to supporting Boost Medical in what’s ahead, as they’re poised to disrupt the personal injury space.”

Trevelino/Keller brings nearly 20 years of brand reputation, media strategy, digital expertise and creative services to its partnership with Boost Medical Group. According to the latest O’Dwyer’s PR Rankings, the firm ranks #2 in Technology, #1 in Healthcare, and #2 in Professional Services in Atlanta.

NLP AiThority News : NLP Leader Huma.AI Launches Industry’s First Generative AI Platform for Life Sciences

 [To share your insights with us, please write to sghosh@martechseries.com] 

The post Boost Medical Group Selects Trevelino/Keller to Launch and Scale New Brand appeared first on AiThority.

diagnostics

life sciences


Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending